Table 1 Patients suffering from NSCLC and on TKI treatment were divided into two groups based on T790M positivity
Group 1 patients | |
Sample size | 25 |
Mutational status | T790M negative (mixture of L858R and exon19 del) |
Age | 45–70 |
Gender | |
Male | 15 |
Female | 10 |
Smoker status | |
Yes | 20 |
No | 5 |
Disease stage | IV |
Histology | Adenocarcinoma |
Group 2 patients | |
Sample size | 25 |
Mutational status | T790M positive (mixture of L858R and exon19 del) |
Age | 56–68 |
Gender | |
Male | 16 |
Female | 9 |
Smoker status | |
Yes | 18 |
No | 7 |
Disease stage | IV |
Histology | Adenocarcinoma |
Healthy volunteers | |
Sample size | 25 |
Age | 40-67 |
Gender | |
Male | 15 |
Female | 10 |
Smoker status | |
Yes | 25 |
No | 0 |